Generali Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Generali Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.7M	Buy	254,617 +1,975	+0.8%	+$113K	0.27%	83
2026 Q1	$15.3M	Sell	252,642 -7,485	-3%	-$436K	0.32%	69
2025 Q4	$14M	Buy	260,127 +17,840	+7%	+$858K	0.29%	76
2025 Q3	$10.9M	Sell	242,287 -47,870	-16%	-$2.24M	0.23%	88
2025 Q2	$13.4M	Buy	290,157 +44,727	+18%	+$2.2M	0.31%	70
2025 Q1	$15M	Sell	245,430 -38,531	-14%	-$2.25M	0.37%	55
2024 Q4	$16.1M	Buy	+283,961	New	+$15.9M	0.41%	49

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Generali Asset Management's BMY Position: Q2 2026 in Review

Generali Asset Management increased its Bristol-Myers Squibb (BMY) stake by 0.78% in Q2 2026, buying an estimated $113K and bringing the position to 254,617 shares worth $14.7M. The position accounts for 0.27% of the portfolio, ranked #83.

Generali Asset Management first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $16.1M in Q4 2024. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Generali Asset Management held 254,617 shares of Bristol-Myers Squibb worth $14.7M as of Q2 2026.
Generali Asset Management bought 1,975 Bristol-Myers Squibb shares in Q2 2026, an estimated $113K.
Bristol-Myers Squibb made up 0.27% of Generali Asset Management's portfolio in Q2 2026, its #83 holding.
Generali Asset Management first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
Generali Asset Management's Bristol-Myers Squibb position peaked at $16.1M in Q4 2024.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Generali Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.